Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"p53 mutants"”.
-
Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven By Different P53 Mutants
… mutations in the DNA binding domain of the Trp53 gene are characterized as structural (p53R172H) or contact (p53R245W) mutations based on their effect on the conformation of the protein. These mutations show gain-of-function activities such as increased metastatic incidence as compared to p53 …
-
Επίδραση μεταλλαγμένων μορφών p53 πρωτεΐνης στη διαταραχή του παλίνδρομου αρνητικού μηχανισμού ανάδρασης P53-MDM2 στον καρκίνο του πνεύμονα
Aim: P53 and MDM2 constitute a negative feedback loop. The coexistence of these two molecules in sarcomas and lung carcinomas has been associated with poor prognosis. In the present PhD study the status of p53 and MDM2 was evaluated in a series of lung carcinomas, and the role of p53 mutants was …
-
The Functional and Clinical Consequences of TP53 Mutations in Cancer
… and therapeutic targets. Mutations in the TP53 gene that encodes the p53 tumor suppressor protein are the most abundant genetic variants in human cancers, yet their clinical utility has not been fully explored. Normally, the p53 protein plays a crucial role as a barrier to cancer. Hundreds …
-
Revealing Novel Regulators of Wildtype and Mutant p53 Stability
Tumour suppressor p53 (TP53) is the most frequently mutated gene in cancer. Several hotspot p53 mutants not only lose tumour suppressive capabilities, but also function in a dominant-negative manner, suppressing canonical wild-type p53 functions. Furthermore, some hotspot p53 mutants promote …
-
Interaction between ATM Kinase and p53 in determining glioma radiosensitivity
… This effect is greater when the tumor suppressor p53 is mutated. The goals of this work include validation of a new ATM inhibitor, AZ32, and elucidation of how ATMi and p53 status interact to promote cell death after radiation. We propose that ATMi and radiation induce mitotic catastrophe in p53 …
-
Mutations in tumour suppressor gene TP53 inform cancer therapy and risk in Li-Fraumeni Syndrome
… mutations in the tumour suppressor gene TP53 and features a distinct cancer spectrum. However, targeted antitumour therapies for LFS and reasons for differential cancer incidence in LFS have yet to be elucidated. Encouragingly, mutant p53 rescuers arsenic trioxide (ATO) and potassium …
-
Contribution of the DNA binding domain of p53 to regulation of its stability
Tumour suppressor p53 is frequently mutated in cancers. While wild type p53 is normally a rapidly degraded protein, mutant forms of p53 are stabilised and accumulate to high levels in tumour cells. Several studies have shown that mutant p53 acquires oncogenic properties and actively contributes to …
-
Analysis of a p53 Gain-of-function Mutation in Transgenic Mouse Salivary Tumors
p53 is an important tumor suppressor gene which is mutated in ~50% of all human cancers. Some of the p53 mutants appear to have acquired novel functions beyond merely losing wild-type functions. To investigate these gain-of-function effects in vivo, we interbred MMTV-v-Ha-ras transgenic mice to …
-
P53 Genes Act to Restrain Mobile Elements
Oncogenic stress provokes tumor suppression by p53 but the extent to which this regulatory axis is conserved remains unknown. Using a biosensor to visualize p53 action, we find that Drosophila p53 is selectively active in gonadal stem cells after exposure to stressors that destabilize the genome. …
-
Nucleation and Condensation of Modified p53: a Baseline to Understand p53 Aggregation
… leading causes of death worldwide. The protein p53 is an important tumor suppressor and is known as the guardian of the genome. This protein is a transcription factor that binds to DNA and controls multiple signaling pathway to determine the cell fate. More than 50 % of human cancers are related …
-
HACAT AS A MODEL FOR KERATINOCYTESTRANSFORMATION
Mutations of the tumor suppressor gene p53 occur in more than 50% of human malignancies and lead to the loss of suppressor activity. Moreover frequently p53 mutants gain novel, oncogenic properties by transcriptional activation of the genes, involved in cellular proliferation, cell survival and …
-
Investigation of Gain-of-Function Induced by Mutant p53
p53 is mutated in 50% of all human cancers, and up to 70% of lung cancer. Mutant p53 is usually expressed at elevated levels in cancer cells and has been correlated with a poor prognosis. Cancer cells that express mutant p53 show an increase in oncogenic phenotypes including an increase in growth …
-
Interplay Between P53 and Epigenetic Pathways in Cancer
The human TP53 gene encodes the most potent tumor suppressor protein p53. More than half of all human cancers contain mutations in the TP53 gene, while the majority of the remaining cases involve other mechanisms to inactivate wild-type p53 function. In the first part of my dissertation research, I …
-
P53 control over cell cycle progression at G2
Tp53 (the human form) is the most commonly mutated tumour suppressor gene found in a large variety of cancers, and appears to be involved in several functions, including DNA damage response, related suppression of inappropriate cell growth, and apoptosis. Wild type p53 is capable of inducing cell …
-
Novel RNA-based biomarkers for ovarian cancer – uncovering how LINC01132 is regulated by the tumour suppressor protein, p53
… 60% of ovarian cancer cases have a mutation in p53, a tumour suppressor transcription factor which counteracts cell stress and oncogenic signals. Most mutations occur within p53’s DNA-binding domain, a vital region which facilitates its anchorage to target gene promoters. Previous data found …
-
A Novel Intramolecular Interaction in P53
The p53 tumor suppressor is a sequence-specific DNA binding protein that activates gene transcription to regulate cell survival and proliferation. The activation process involves post-translational modifications that suppress p53 degradation by MDM2 and increase p53 DNA binding affinity. p53 is …
-
UNDERSTANDING THE RELATIONSHIP BETWEEN ONCOLYTIC AD5 DELETED E1b55KDA LYTIC INFECTION AND P53 IN MAMMALIAN CELLS
… replicate in and kill tumor cells. The p53 molecule is a tumor suppressor protein that responds to viral infection through the activation of apoptosis, which is inhibited by adenovirus E1B55kDa protein leading to progressive viral lytic cycle. The non-specificity of replication has …
-
Computational investigation of the DNA binding domain of p53: a drive towards novel therapeutics
p53 is a marginally stable protein that is mutated in 50 % of all human cancers [1]. The region of the protein that contains most of these mutations is the DNA binding domain (DBD). This DBD controls the transcription of p53-dependent genes through the binding of DNA, and is the main focus of the …
-
A Step Closer to Precision Oncology: Computational, Biochemical, and Cell-Based Screening to Find Compounds that Stabilize p53
… affect a large population of cancer patients is p53. p53 is a tumor suppressor that activates senescence or apoptosis in cells that have accumulated mutations that could lead to cancer. Half of all cancers have mutations in p53, which highlights the importance of its role in disease. A subset of …
-
Targeting mutant p53 in cSCCs
… patients with multiple cSCCs.<br/><br/>Wild-type p53 (wt-p53) has been shown to prevent cSCC development and induce tanning and sunburn responses in skin cells. However, TP53 mutations are found in over half of all human cancers and cSCC is no exception as TP53 mutational frequency in cSCCs is …
Page 1 of 2